Clinical leaders report need to unify clinical operations

4 April 2019
rik_van_mol_veeva_large

An Expert View on a growing trend among drug developers from Rik Van Mol, vice president of R&D strategy, Europe, Veeva Systems.

A majority of life sciences companies are taking action to unify clinical processes to improve trial performance, according to a survey. Results from the Veeva 2018 Unified Clinical Operations Survey reveal that nearly all (99%) clinical leaders acknowledge the need to unify their clinical operating environments, and most (87%) have plans in place to get there. Here’s what we learned:

Need for better visibility and faster trial execution

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical